Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (261-270 of 323) with videos related to

Pageof 33
Sort By:
Urologic Oncology|March 15, 2011
Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapyAndreas Meyer, Irina Coinac, Natalia Bogdanova, et al.
Urologie (Heidelberg, Germany)|April 7, 2025
[Making prostate cancer research accessible: chatGPT-4 as a tool to enhance lay communication]Maximilian Haas, Veronika Saberi, Christopher Gossler, et al.
Journal of Medical Internet Research|November 19, 2025
Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance EvaluationEmily Rinderknecht, Simon U Engelmann, Veronika Saberi, et al.
BJU International|October 27, 2024
An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trialJulian Peter Struck, Nadim Moharam, Armin Leitenberger, et al.
European Urology|December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal CancerThomas Powles, Laurence Albiges, Michael Staehler, et al.
Urologic Oncology|June 11, 2019
TRIM24 as an independent prognostic biomarker for prostate cancerAnne Offermann, Doris Roth, Marie Christine Hupe, et al.
Advances in Therapy|October 23, 2020
Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World ScenarioJulian P Struck, Mario W Kramer, Olga Katzendorn, et al.
Clinical Genitourinary Cancer|December 12, 2018
Imaging in Suspected Renal-Cell Carcinoma: Systematic ReviewChristina Vogel, Brigitte Ziegelmüller, Börje Ljungberg, et al.
Frontiers in Oncology|December 16, 2021
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, et al.
The Lancet. Oncology|March 12, 2017
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trialKim N Chi, Celestia S Higano, Brent Blumenstein, et al.
Pageof 33

Showing results (261-270 of 323) with videos related to

Sort By:
Pageof 33
Urologic Oncology|March 15, 2011
Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapyAndreas Meyer, Irina Coinac, Natalia Bogdanova, et al.
Urologie (Heidelberg, Germany)|April 7, 2025
[Making prostate cancer research accessible: chatGPT-4 as a tool to enhance lay communication]Maximilian Haas, Veronika Saberi, Christopher Gossler, et al.
Journal of Medical Internet Research|November 19, 2025
Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance EvaluationEmily Rinderknecht, Simon U Engelmann, Veronika Saberi, et al.
BJU International|October 27, 2024
An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trialJulian Peter Struck, Nadim Moharam, Armin Leitenberger, et al.
European Urology|December 11, 2017
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal CancerThomas Powles, Laurence Albiges, Michael Staehler, et al.
Urologic Oncology|June 11, 2019
TRIM24 as an independent prognostic biomarker for prostate cancerAnne Offermann, Doris Roth, Marie Christine Hupe, et al.
Advances in Therapy|October 23, 2020
Bicentric Retrospective Analysis of en Bloc Resection and Muscularis Mucosae Detection Rate in Non-Muscle Invasive Bladder Tumors: A Real-World ScenarioJulian P Struck, Mario W Kramer, Olga Katzendorn, et al.
Clinical Genitourinary Cancer|December 12, 2018
Imaging in Suspected Renal-Cell Carcinoma: Systematic ReviewChristina Vogel, Brigitte Ziegelmüller, Börje Ljungberg, et al.
Frontiers in Oncology|December 16, 2021
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, et al.
The Lancet. Oncology|March 12, 2017
Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trialKim N Chi, Celestia S Higano, Brent Blumenstein, et al.
Pageof 33